Cadrenal Therapeutics Inc (CVKD)

Jul 01, 2026

Cadrenal (CVKD) CEO sells 7,400 shares, retains direct and trust stakes - Stock Titan

Jul 01, 2026

Jul 01, 2026

Cadrenal Therapeutics CEO sells $22,422 in stock By Investing.com - Investing.com Australia

Jul 01, 2026

Jul 01, 2026

Form 4 Cadrenal Therapeutics Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

Jul 01, 2026

(CVKD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jul 01, 2026

Jul 01, 2026

Cadrenal Therapeutics Raises $3.0 Million in Private Placement of Pre-Funded and Common Warrants - TradingView

Jul 01, 2026

Jul 01, 2026

Cadrenal Therapeutics (NASDAQ: CVKD) lines up up to $8.8M via private placement - Stock Titan

Jul 01, 2026

Jul 01, 2026

Cadrenal Therapeutics Enters Upto $8.8 Mln Private Placement To Extend Cash Runway; Stock Down - RTTNews

Jul 01, 2026

Jun 30, 2026

Cadrenal Therapeutics raises $3 million in private placement - Investing.com

Jun 30, 2026

Jun 30, 2026

Cadrenal Therapeutics raises $3 million in private placement By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 30, 2026

Cadrenal Therapeutics Announces $3 Million Private Placement with Potential Additional $5.8 Million from Warrants - Quiver Quantitative

Jun 30, 2026

Jun 30, 2026

Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jun 30, 2026

Jun 29, 2026

Cadrenal Therapeutics Appoints Interim CFO John Sharp Under Master Services Agreement with Lohman & Associates - Minichart

Jun 29, 2026

Jun 29, 2026

Cadrenal Therapeutics Names Sharp Interim CFO - Moomoo

Jun 29, 2026

Jun 29, 2026

Cadrenal Therapeutics Board Member Steven Zelenkofske Resigns - Moomoo

Jun 29, 2026

Jun 29, 2026

Cadrenal Names Interim CFO, Realigns Board Structure - TipRanks

Jun 29, 2026

Jun 29, 2026

Cadrenal Therapeutics (NASDAQ: CVKD) names interim CFO and realigns board classes - Stock Titan

Jun 29, 2026

Jun 27, 2026

Cadrenal therapeutics CEO Pham sells $33,919 in stock By Investing.com - Investing.com South Africa

Jun 27, 2026

Jun 27, 2026

Price to earnings forward of Cadrenal Therapeutics, Inc. – NASDAQ:CVKD - TradingView

Jun 27, 2026

Jun 27, 2026

Price to sales forward of Cadrenal Therapeutics, Inc. – NASDAQ:CVKD - TradingView

Jun 27, 2026

Jun 26, 2026

Cadrenal Therapeutics (CVKD) CEO Quang Pham sells 11,156 shares under 10b5-1 plan - Stock Titan

Jun 26, 2026

Jun 26, 2026

Form 4 Cadrenal Therapeutics Inc For: 26 June By Investing.com - Investing.com Canada

Jun 26, 2026

Jun 26, 2026

Cadrenal Therapeutics, Inc. Actuals & Estimates (NASDAQ:CVKD) - TradingView

Jun 26, 2026

Jun 25, 2026

CVKD Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Cadrenal Therapeutics chairman and CEO Pham sells $39,829 in stock. By Investing.com - Investing.com South Africa

Jun 24, 2026

Jun 24, 2026

Cadrenal Therapeutics chairman and CEO Pham sells $39,829 in stock. - Investing.com

Jun 24, 2026

Jun 24, 2026

Form 4 Cadrenal Therapeutics Inc For: 24 June By Investing.com - Investing.com Australia

Jun 24, 2026

Jun 24, 2026

Cadrenal (CVKD) CEO Quang Pham sells 11,444 shares in planned 10b5-1 trades - Stock Titan

Jun 24, 2026

Jun 24, 2026

Cadrenal’s HIT drug data selected for presentation at Paris congress - Investing.com UK

Jun 24, 2026

Jun 24, 2026

Cadrenal’s HIT drug data selected for presentation at Paris congress By Investing.com - Investing.com South Africa

Jun 24, 2026

Jun 24, 2026

Cadrenal’s HIT drug gets late-breaking oral slot at ISTH 2026 - Stock Titan

Jun 24, 2026

Jun 22, 2026

Cadrenal Therapeutics Inc (CVKD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026

Jun 18, 2026

Cadrenal CEO Pham sells $13,110 in company stock By Investing.com - Investing.com South Africa

Jun 18, 2026

Jun 18, 2026

Cadrenal CEO Pham sells $13,110 in company stock - Investing.com

Jun 18, 2026

Jun 18, 2026

Cadrenal (CVKD) CEO Pham sells 4,126 shares, retains large stake via trust - Stock Titan

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics (CVKD) Pursues FDA Designation for Pediatric Treatment - GuruFocus

Jun 18, 2026

Jun 18, 2026

What date does Cadrenal Therapeutics, Inc.'s (CVKD) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Jun 18, 2026

Jun 18, 2026

Cadrenal plans rare pediatric disease designation for tecarfarin - Investing.com

Jun 18, 2026

Jun 18, 2026

Cadrenal Pursues Rare Pediatric Designation for Tecarfarin - TipRanks

Jun 18, 2026

Jun 18, 2026

Cadrenal plans rare pediatric disease designation for tecarfarin By Investing.com - Investing.com South Africa

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics To Submit FDA Rare Pediatric Disease Designation Request For Tecarfarin In Kawasaki Disease - TradingView

Jun 18, 2026

Jun 18, 2026

Pediatric voucher play: Cadrenal (NASDAQ: CVKD) eyes tecarfarin RPDD - Stock Titan

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease - GlobeNewswire

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics Inc (CVKD) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics Inc (CVKD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

Cadrenal Therapeutics Inc (CVKD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026

Jun 17, 2026

Cadrenal Therapeutics Inc (CVKD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Cadrenal Therapeutics Inc (CVKD) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Cadrenal Therapeutics Inc (CVKD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026